Last reviewed · How we verify
PARAFFIN
At a glance
| Generic name | PARAFFIN |
|---|---|
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma (NA)
- Efficacy of Paraffin Bath and Peloidotherapy in Carpal Tunnel Syndrome (NA)
- A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) (NA)
- GYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian Cohort
- Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger (NA)
- A1 Pulley Stretching Along With Tendon Gliding Exercises in Post-operative Patients of Trigger Finger (NA)
- Prevention of Incontinence-associated Dermatitis (NA)
- Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PARAFFIN CI brief — competitive landscape report
- PARAFFIN updates RSS · CI watch RSS